Novo Nordisk: Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.
Read full article »
Novo Nordisk is a Denmark-based multinational pharmaceutical company that develops and commercializes diabetes care medications and devices for the healthcare industry.
Read more